sparfloxacin has been researched along with Pseudomonas Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, K; Egawa, H; Fujita, M; Kataoka, M; Matsumoto, J; Minamida, A; Miyamoto, T; Nishimura, Y; Okada, H; Shibamori, K | 1 |
| Iwagaki, A; Matsumoto, K; Nagatake, T; Oishi, K; Pollack, M; Ponglertnapagorn, P; Siadak, A; Sonoda, F; Watanabe, K | 1 |
| Iwagaki, A; Kobayashi, S; Matsumoto, K; Nagatake, T; Oishi, K; Sonoda, F | 1 |
3 other study(ies) available for sparfloxacin and Pseudomonas Infections
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Molecular Conformation; Phenylbutyrates; Pseudomonas Infections; Rats; Streptococcal Infections; Structure-Activity Relationship; Theophylline; X-Ray Diffraction | 1990 |
Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Infective Agents; Antibodies, Monoclonal; Bacteremia; Cell Movement; Female; Flagella; Fluoroquinolones; Humans; Lipopolysaccharides; Lung; Mice; Mice, Inbred ICR; Neutropenia; Opsonin Proteins; Phagocytosis; Pneumonia; Pseudomonas Infections; Quinolones; Serotyping | 1993 |
Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Antibodies, Monoclonal; Cyclophosphamide; Drug Therapy, Combination; Female; Fluoroquinolones; Immunoglobulin G; Injections, Intravenous; Lipopolysaccharides; Lung; Mice; Mice, Inbred ICR; Neutropenia; Pneumonia; Pseudomonas Infections; Quinolones | 1992 |